Managing BRAF V600-mutant Colorectal Cancer

Colorectal cancer (CRC) continues to be the second most lethal cancer in the United States (US) with approximately 149,500 new cases and 52,980 deaths per year. Patients diagnosed at an advanced/metastatic stage have a five-year survival rate of roughly 14%. For these...

Oncology Innovations: Metastatic Non-Small Cell Lung Cancer

This interactive program updates learners on the latest guideline recommendations for biomarker identification and application in NSCLC. The program will enable learners to select appropriate personalized treatment pathways based on the tumor profile, while...